Theratechnologies Inc T.TH

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

[Trogarzon]

Should read How to turn a Million into 50k over three decades...  

[scarlet1967]

Winning With Partnerships: How To Turn A Three-Decade-Old Biotech Profitable Winning With Partnerships: How To Turn A Three-Decade-Old Biotech Profitable I don't have access to the article but

[Trogarzon]

Like SPCEO said there must be a pickle with Egrifta manaufacturing since we were told that early november would see the PSA filed and the 4 months revision timeline started.  Nothing yet so it

[Lee430]

I must say it feels like we are on the precipice of either total collapse from Engrifa SV & F8 debacles or something spectacular with TH1902 results & partnerships….Unfortunately with Thera’s

[Trogarzon]

The only espectations I have is for the spending on Th1902 will stop and the whole program will be benched like the Nash progrma for lack of interest from a partner unless truly amazing results come

[PWIB123]

I see this as primarily a negative for THTX.  They've wasted the possibility of playing in the NASH/MASH space as others race forward with potential drugs that could hit the market.  At

[Jonathon Brown]

A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results. read article.

[Trogarzon]

So what in store between now and the end of the year... Egrifta shortage (unreal), F8 (ok, can't manufacture F4 atm), TH1902 (no news is good news.. at least not bad news yet).  I'm sure

[Trogarzon]

At least that's burried overthere. Can't imagine the waste of money that would have been.

[palinc2000]

https://seekingalpha.com/news/4309561-novo-nordisksemaglutidephase-3-trialfor-mas-hmeetsprimaryendpoints

[palinc2000]

https://seekingalpha.com/news/4309209-viking-phase-2b-study-of-nash-candidate-hits-primary-endpoint

[Trogarzon]

What would define results deemed good enough to secure a decent partnership.  I heard of at least 30% patient response and 30% improvement over existing therapies. Something like that.

[Trogarzon]

Well, if there is an issue with Egrifta we should know about it.  I've been asking since Oct. 21 if the batch was produced. They know and it's material.  When and if we ear that they

[SPCEO1]

Yes, still check here every now and again. Still own our position. BTW, so do all the other large shareholders according to their updated SEC filings through 9/30/24. Clearly, there is an issue with

[JayjayUSA12007]

Just wonder...

[Trogarzon]

The World is changing so must Thera.  Make Thera great again.. lol.